These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2192443)

  • 21. Cavernous nerve graft reconstruction during radical prostatectomy or radical cystectomy: safe and technically feasible.
    Anastasiadis AG; Benson MC; Rosenwasser MP; Salomon L; El-Rashidy H; Ghafar MA; McKiernan JM; Burchardt M; Shabsigh R
    Prostate Cancer Prostatic Dis; 2003; 6(1):56-60. PubMed ID: 12664067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer.
    Zincke H; Oesterling JE; Blute ML; Bergstralh EJ; Myers RP; Barrett DM
    J Urol; 1994 Nov; 152(5 Pt 2):1850-7. PubMed ID: 7523733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostate cancer at the peripheral end of a prostate biopsy specimen as assessed by a novel marking technique may indicate increased risk of locally advanced disease.
    Ponholzer A; Rauchenwald M; Rainer-Concin A; Hummer B; Fink K; Szlauer R; Schmeller N; Madersbacher S
    Prostate Cancer Prostatic Dis; 2011 Mar; 14(1):69-73. PubMed ID: 21060328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is preoperative transrectal ultrasonography of value in localised prostatic carcinoma? A blind comparative study between preoperative transrectal ultrasonography and the histopathological radical prostatectomy specimen.
    Vijverberg PL; Giessen MC; Kurth KH; Dabhoiwala NF; de Reijke TM; van den Tweel JG
    Eur J Surg Oncol; 1992 Oct; 18(5):449-55. PubMed ID: 1426295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases.
    Partin AW; Pearson JD; Landis PK; Carter HB; Pound CR; Clemens JQ; Epstein JI; Walsh PC
    Urology; 1994 May; 43(5):649-59. PubMed ID: 7513108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The value of transrectal MRI in the staging of localized prostate cancer].
    Pariente JL; Jacob F; Trillaud H; Deminiere C; Khan H; Ferrière JM; Grenier N; Le Guillou M
    Prog Urol; 1997 Jun; 7(3):449-54. PubMed ID: 9273074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Positive Surgical Margins after Radical Prostatectomy on Disease Progression and Adjuvant Treatment in Pathologically Localized Prostate Cancer.
    Tomasković I; Milicić V; Tomić M; Ruzić B; Ulamec M
    Coll Antropol; 2015 Sep; 39(3):697-700. PubMed ID: 26898068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Preoperative staging of prostatic carcinoma: evaluation of the role of transrectal echography].
    Lorusso A; Curatolo C; Cirillo Marucco E; Ludovico GM; Limitone DA; Pagliarulo A
    Arch Ital Urol Androl; 1996 Dec; 68(5 Suppl):83-5. PubMed ID: 9162382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparison of rectal examination, transrectal echography, CAT and MRI in the local staging of prostatic carcinoma].
    Montorsi F; Guazzoni G; Consonni P; Colombo R; Nava L; Bergamaschi F; Scattoni V; Rigatti P
    Arch Ital Urol Nefrol Androl; 1991 Jun; 63 Suppl 2():143-5. PubMed ID: 1836654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Transrectal echography of the prostate and its value in screening for prostatic carcinoma].
    Kil PJ; Hendrikx AJ; Debruyne FM
    Ned Tijdschr Geneeskd; 1990 Feb; 134(8):385-90. PubMed ID: 2179743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of biochemical recurrence after Retzius-sparing robot-assisted radical prostatectomy: Analysis of 359 cases with a median follow-up period of 26 months.
    Abdel Raheem A; Chang KD; Alenzi MJ; Ham WS; Han WK; Choi YD; Rha KH
    Int J Urol; 2018 Dec; 25(12):1006-1014. PubMed ID: 30276864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current results and patient selection for nerve-sparing radical retropubic prostatectomy.
    Steiner MS
    Semin Urol Oncol; 1995 Aug; 13(3):204-14. PubMed ID: 8521134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The value of prostate specific antigen and transrectal ultrasound guided biopsy in detecting prostatic fossa recurrences following radical prostatectomy.
    Foster LS; Jajodia P; Fournier G; Shinohara K; Carroll P; Narayan P
    J Urol; 1993 May; 149(5):1024-8. PubMed ID: 7683341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patients with abnormal ultrasound of the prostate but normal digital rectal examination should be classified as having clinical stage T2 tumors.
    Tiguert R; Gheiler EL; Grignon DJ; Littrup PJ; Sakr W; Pontes JE; Wood DP
    J Urol; 2000 May; 163(5):1486-90. PubMed ID: 10751863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic value of transrectal ultrasound in tumor staging and in the detection of incidental prostatic cancer.
    Grups JW; Gruss A; Wirth M; Frohmüller HG
    Urol Int; 1990; 45(1):38-40. PubMed ID: 2407012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radical prostatectomy in the management of stage-A carcinoma of the prostate.
    Rossignol G; Leandri P; Ramon J; Gautier JR
    Eur Urol; 1991; 20(3):179-83. PubMed ID: 1823039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Local recurrence after radical prostatectomy: characteristics in size, location, and relationship to prostate-specific antigen and surgical margins.
    Connolly JA; Shinohara K; Presti JC; Carroll PR
    Urology; 1996 Feb; 47(2):225-31. PubMed ID: 8607239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome.
    Ward JF; Slezak JM; Blute ML; Bergstralh EJ; Zincke H
    BJU Int; 2005 Apr; 95(6):751-6. PubMed ID: 15794776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Preliminary results of the treatment of 44 patients with localized cancer of the prostate using transrectal focused ultrasound].
    Gelet A; Chapelon JY; Bouvier R; Pangaud C; Souchon R; Blanc E; Cathignol D; Dubernard JM
    Prog Urol; 1998 Feb; 8(1):68-77. PubMed ID: 9533155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Echogenic structure of prostatic cancer imaged on radical prostatectomy specimens.
    Salo JO; Rannikko S; Mäkinen J; Lehtonen T
    Prostate; 1987; 10(1):1-9. PubMed ID: 3547365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.